Structure-Based Design of 5Methylpyrimidopyridone Derivatives as New Wild-Type Sparing Inhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFRL858R/T790M/C797S)

doi 10.1021/acs.jmedchem.9b00576.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA - Journal of the American Medical Association
Medicine
2014English

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

Tumor Biology
MedicineCancer Research
2017English

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2010English

Identification of Antiproliferative Emodin Analogues as Inhibitors of Epidermal Growth Factor Receptor in Cancer

International Journal of Molecular Medicine
MedicineGenetics
2019English

Regulation of Epidermal Growth Factor Receptor Signalling by Inducible Feedback Inhibitors

Journal of Cell Science
Cell Biology
2011English

Association of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment and EGFR Exon 19 Deletion With Frequency of the T790M Mutation in Non-Small Cell Lung Cancer Patients After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

OncoTargets and Therapy
OncologyPharmacology
2019English

Quantification of Epidermal Growth Factor Receptor T790M Mutant Transcripts in Lung Cancer Cells by Real-Time Reverse Transcriptase–quantitative Polymerase Chain Reaction

Analytical Biochemistry
BiochemistryCell BiologyMolecular BiologyBiophysics
2010English

Clinical Significance of the Mutant Epidermal Growth Factor Receptor "ΔEGFR" in Astrocytic Tumors

Japanese Journal of Neurosurgery
SurgeryNeurology
2003English

In Vitro and in Vivo Characterization of Irreversible Mutant-Selective EGFR Inhibitors That Are Wild-Type Sparing

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy